{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:26:40Z","timestamp":1793852800964,"version":"4.6.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The 2022 global mpox outbreak highlighted the risk of zoonotic diseases establishing sustained transmission in human populations and underscored the need for accurate serological tools to monitor orthopoxvirus exposure. However, cross-reactive antibodies induced by Modified Vaccinia Ankara (MVA) vaccination make it difficult to discriminate between monkeypox virus (MPXV) infection and vaccination-induced immunity. Here we present a machine learning (ML)-assisted bead-based serological multiplex assay that distinguishes MPXV infection from MVA vaccination and pre-immune sera by targeting antibody responses to 15 poxviral antigens. Of the six algorithms tested, the Gradient Boosting Classifier (GBC) achieves the highest performance (F1\u2009=\u20090.83) in sera from the 2022 outbreak and from a follow-up epidemiological cohort of at-risk men who have sex with men (MSM; n\u2009=\u20091,260). In an independent validation cohort (n\u2009=\u2009143), GBC (F1\u2009=\u20090.70) robustly detects MPXV infections, including breakthrough cases, with 88% specificity and 92% sensitivity. Integrating ML with high-dimensional serology enables accurate cross-sectional classification of orthopoxvirus immune status and provides a scalable framework for mpox serosurveillance and outbreak preparedness.<\/jats:p>","DOI":"10.1038\/s41467-025-66994-0","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:36:03Z","timestamp":1764941763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Machine learning-supported framework for the classification of mpox infection and MVA immunization from multiplexed serology data"],"prefix":"10.1038","volume":"16","author":[{"given":"Rebecca","family":"Surtees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fridolin","family":"Treindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2927-1974","authenticated-orcid":false,"given":"Shakhnaz","family":"Akhmedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-7896","authenticated-orcid":false,"given":"Denis","family":"Beslic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-5850","authenticated-orcid":false,"given":"Fatimanur","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2954-2957","authenticated-orcid":false,"given":"Akin","family":"Sesver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My Linh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-8203","authenticated-orcid":false,"given":"Marica","family":"Grossegesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Skiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6227-3125","authenticated-orcid":false,"given":"Janine","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2506-4297","authenticated-orcid":false,"given":"Nils","family":"K\u00f6rber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-9421","authenticated-orcid":false,"given":"Klaus","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9718-5811","authenticated-orcid":false,"given":"Uwe","family":"Koppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3143-2717","authenticated-orcid":false,"given":"Ulrich","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4373-9713","authenticated-orcid":false,"given":"Nicole","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0131-5739","authenticated-orcid":false,"given":"Annette","family":"Mankertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3397-1308","authenticated-orcid":false,"given":"Katharina","family":"Ladewig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Werner","family":"Mages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-2546","authenticated-orcid":false,"given":"Brigitte G.","family":"Dorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-3176","authenticated-orcid":false,"given":"Andreas","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-4283","authenticated-orcid":false,"given":"Daniel","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"66994_CR1","doi-asserted-by":"publisher","unstructured":"Silva, N. I. O., de Oliveira, J. S., Kroon, E. G., Trindade, G. S. & Drumond, B. P. Here, there, and everywhere: the wide host range and geographic distribution of zoonotic orthopoxviruses. Viruses https:\/\/doi.org\/10.3390\/v13010043 (2020).","DOI":"10.3390\/v13010043"},{"key":"66994_CR2","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1073\/pnas.1005769107","volume":"107","author":"AW Rimoin","year":"2010","unstructured":"Rimoin, A. W. et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc. Natl Acad. Sci. USA 107, 16262\u201316267 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"66994_CR3","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/S0140-6736(23)00588-3","volume":"401","author":"I Adetifa","year":"2023","unstructured":"Adetifa, I., Muyembe, J. J., Bausch, D. G. & Heymann, D. L. Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world. Lancet 401, 1822\u20131824 (2023).","journal-title":"Lancet"},{"key":"66994_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","volume":"22","author":"FM Lum","year":"2022","unstructured":"Lum, F. M. et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat. Rev. Immunol. 22, 597\u2013613 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"66994_CR5","doi-asserted-by":"publisher","first-page":"e0007791","DOI":"10.1371\/journal.pntd.0007791","volume":"13","author":"EM Beer","year":"2019","unstructured":"Beer, E. M. & Rao, V. B. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl. Trop. Dis. 13, e0007791 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"66994_CR6","doi-asserted-by":"publisher","unstructured":"Selb, R. et al. A shift from travel-associated cases to autochthonous transmission with Berlin as epicentre of the monkeypox outbreak in Germany, May to June 2022. Euro Surveill https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.27.2200499(2022).","DOI":"10.2807\/1560-7917.ES.2022.27.27.2200499"},{"key":"66994_CR7","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe. Mpox, Joint Epidemiological Overview, https:\/\/monkeypoxreport.ecdc.europa.eu\/ (2024)."},{"key":"66994_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill, J. P. et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. N. Engl. J. Med. 387, 679\u2013691 (2022).","journal-title":"N. Engl. J. Med."},{"key":"66994_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1473-3099(23)00451-6","volume":"24","author":"XS Zhang","year":"2024","unstructured":"Zhang, X. S. et al. Transmission dynamics and effect of control measures on the 2022 outbreak of mpox among gay, bisexual, and other men who have sex with men in England: a mathematical modelling study. Lancet Infect. Dis. 24, 65\u201374 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"66994_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/OLQ.0000000000001889","volume":"51","author":"CE Copen","year":"2024","unstructured":"Copen, C. E. et al. Modifications to sexual behaviors associated with Mpox (Monkeypox) virus transmission among persons presenting for mpox Vaccination, Washington, DC, August-October, 2022. Sex. Transm. Dis. 51, 54\u201360 (2024).","journal-title":"Sex. Transm. Dis."},{"key":"66994_CR11","doi-asserted-by":"publisher","unstructured":"Gubela, N. et al. Transient behavior changes and depletion of susceptibles in high contact groups led to case decline during 2022 mpox outbreak in MSM in Berlin. PREPRINT (Version 1) available at Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-6254021\/v1 (2025).","DOI":"10.21203\/rs.3.rs-6254021\/v1"},{"key":"66994_CR12","unstructured":"World Health Organization (WHO). Mpox - Democratic Republic of the Congo, https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2024-DON522 (2024)."},{"key":"66994_CR13","unstructured":"World Health Organization (WHO). Fifth Meeting of the International Health Regulations (2005) (IHR) Emergency Committee on the Multi-Country Outbreak of mpox (monkeypox), https:\/\/bit.ly\/4fCa7VS (2023)."},{"key":"66994_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41587-x","volume":"14","author":"AD Otter","year":"2023","unstructured":"Otter, A. D. et al. Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals. Nat. Commun. 14, 5948 (2023).","journal-title":"Nat. Commun."},{"key":"66994_CR15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4269\/ajtmh.2010.09-0716","volume":"82","author":"MG Reynolds","year":"2010","unstructured":"Reynolds, M. G. et al. A silent enzootic of an orthopoxvirus in Ghana, West Africa: evidence for multi-species involvement in the absence of widespread human disease. Am. J. Trop. Med Hyg. 82, 746\u2013754 (2010).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"66994_CR16","doi-asserted-by":"publisher","unstructured":"Leendertz, S. A. J. et al. A cross-sectional serosurvey of anti-orthopoxvirus antibodies in Central and Western Africa. Viruses https:\/\/doi.org\/10.3390\/v9100278 (2017).","DOI":"10.3390\/v9100278"},{"key":"66994_CR17","doi-asserted-by":"publisher","first-page":"e29261","DOI":"10.1002\/jmv.29261","volume":"95","author":"M Grossegesse","year":"2023","unstructured":"Grossegesse, M. et al. Serological methods for the detection of antibodies against monkeypox virus applicable for laboratories with different biosafety levels. J. Med. Virol. 95, e29261 (2023).","journal-title":"J. Med. Virol."},{"key":"66994_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1586\/14760584.8.1.13","volume":"8","author":"JS Kennedy","year":"2009","unstructured":"Kennedy, J. S. & Greenberg, R. N. IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine. Expert Rev. Vaccines 8, 13\u201324 (2009).","journal-title":"Expert Rev. Vaccines"},{"key":"66994_CR19","unstructured":"European Medicines Agency. EMA Recommends Approval of Imvanex For the Prevention of Monkeypox Disease, https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-approval-imvanex-prevention-monkeypox-disease (2022)."},{"key":"66994_CR20","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm917","volume":"9","author":"E Hammarlund","year":"2003","unstructured":"Hammarlund, E. et al. Duration of antiviral immunity after smallpox vaccination. Nat. Med 9, 1131\u20131137 (2003).","journal-title":"Nat. Med"},{"key":"66994_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41392-023-01574-6","volume":"8","author":"E Li","year":"2023","unstructured":"Li, E. et al. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus. Signal Transduct. Target Ther. 8, 350 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"66994_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.virol.2005.07.006","volume":"341","author":"L Aldaz-Carroll","year":"2005","unstructured":"Aldaz-Carroll, L. et al. Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene. Virology 341, 59\u201371 (2005).","journal-title":"Virology"},{"key":"66994_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1006\/viro.1999.0096","volume":"266","author":"JW Hooper","year":"2000","unstructured":"Hooper, J. W., Custer, D. M., Schmaljohn, C. S. & Schmaljohn, A. L. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Virology 266, 329\u2013339 (2000).","journal-title":"Virology"},{"key":"66994_CR24","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1128\/JVI.01854-07","volume":"82","author":"A Berhanu","year":"2008","unstructured":"Berhanu, A. et al. Vaccination of BALB\/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. J. Virol. 82, 3517\u20133529 (2008).","journal-title":"J. Virol."},{"key":"66994_CR25","doi-asserted-by":"publisher","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","volume":"79","author":"DH Davies","year":"2005","unstructured":"Davies, D. H. et al. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J. Virol. 79, 11724\u201311733 (2005).","journal-title":"J. Virol."},{"key":"66994_CR26","doi-asserted-by":"publisher","unstructured":"Diesterbeck, U. S. et al. Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library. Vaccines https:\/\/doi.org\/10.3390\/vaccines9111308 (2021).","DOI":"10.3390\/vaccines9111308"},{"key":"66994_CR27","doi-asserted-by":"publisher","first-page":"e1004495","DOI":"10.1371\/journal.ppat.1004495","volume":"10","author":"MH Matho","year":"2014","unstructured":"Matho, M. H. et al. Murine anti-vaccinia virus D8 antibodies target different epitopes and differ in their ability to block D8 binding to CS-E. PLoS Pathog. 10, e1004495 (2014).","journal-title":"PLoS Pathog."},{"key":"66994_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1099\/0022-1317-83-1-209","volume":"83","author":"M Law","year":"2002","unstructured":"Law, M., Hollinshead, R. & Smith, G. L. Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J. Gen. Virol. 83, 209\u2013222 (2002).","journal-title":"J. Gen. Virol."},{"key":"66994_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","volume":"325","author":"E Bell","year":"2004","unstructured":"Bell, E. et al. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin. Virology 325, 425\u2013431 (2004).","journal-title":"Virology"},{"key":"66994_CR30","doi-asserted-by":"publisher","first-page":"e21950","DOI":"10.1371\/journal.pone.0021950","volume":"6","author":"L Miller","year":"2011","unstructured":"Miller, L., Richter, M., Hapke, C., Stern, D. & Nitsche, A. Genomic expression libraries for the identification of cross-reactive orthopoxvirus antigens. PLoS One 6, e21950 (2011).","journal-title":"PLoS One"},{"key":"66994_CR31","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.vaccine.2011.11.021","volume":"30","author":"G Hermanson","year":"2012","unstructured":"Hermanson, G. et al. Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax using proteome microarrays and development of recombinant protein ELISAs. Vaccine 30, 614\u2013625 (2012).","journal-title":"Vaccine"},{"key":"66994_CR32","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1128\/JVI.02244-07","volume":"82","author":"MR Benhnia","year":"2008","unstructured":"Benhnia, M. R. et al. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. J. Virol. 82, 3751\u20133768 (2008).","journal-title":"J. Virol."},{"key":"66994_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10066-z","volume":"24","author":"U Marcus","year":"2024","unstructured":"Marcus, U. et al. A seroprevalence study indicates a high proportion of clinically undiagnosed MPXV infections in men who have sex with men in Berlin, Germany. BMC Infect. Dis. 24, 1153 (2024).","journal-title":"BMC Infect. Dis."},{"key":"66994_CR34","doi-asserted-by":"publisher","unstructured":"Rebecca, S. et al. Data set for manuscript: Machine learning-supported framework for the classification of mpox infection and MVA immunization from multiplexed serology data. figshare. Dataset. https:\/\/doi.org\/10.6084\/m9.figshare.26391226 (2025).","DOI":"10.6084\/m9.figshare.26391226"},{"key":"66994_CR35","doi-asserted-by":"publisher","first-page":"105622","DOI":"10.1016\/j.ebiom.2025.105622","volume":"113","author":"J Byrne","year":"2025","unstructured":"Byrne, J. et al. Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccination. EBioMedicine 113, 105622 (2025).","journal-title":"EBioMedicine"},{"key":"66994_CR36","doi-asserted-by":"publisher","first-page":"100987","DOI":"10.1016\/j.lanmic.2024.100987","volume":"6","author":"S Jones","year":"2025","unstructured":"Jones, S. et al. Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study. Lancet Microbe 6, 100987 (2025).","journal-title":"Lancet Microbe"},{"key":"66994_CR37","doi-asserted-by":"publisher","first-page":"e28429","DOI":"10.1002\/jmv.28429","volume":"95","author":"CK Lim","year":"2023","unstructured":"Lim, C. K. et al. Mpox diagnostics: Review of current and emerging technologies. J. Med Virol. 95, e28429 (2023).","journal-title":"J. Med Virol."},{"key":"66994_CR38","doi-asserted-by":"publisher","first-page":"115004","DOI":"10.1016\/j.jviromet.2024.115004","volume":"329","author":"JH Hunt","year":"2024","unstructured":"Hunt, J. H. et al. Discordant performance of mpox serological assays. J. Virol. Methods 329, 115004 (2024).","journal-title":"J. Virol. Methods"},{"key":"66994_CR39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3201\/eid1404.071044","volume":"14","author":"ME Dubois","year":"2008","unstructured":"Dubois, M. E. & Slifka, M. K. Retrospective analysis of monkeypox infection. Emerg. Infect. Dis. 14, 592\u2013599 (2008).","journal-title":"Emerg. Infect. Dis."},{"key":"66994_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jmv.1890010107","volume":"1","author":"JJ Esposito","year":"1977","unstructured":"Esposito, J. J., Obijeski, J. F. & Nakano, J. H. Serological relatedness of monkeypox, variola, and vaccinia viruses. J. Med Virol. 1, 35\u201347 (1977).","journal-title":"J. Med Virol."},{"key":"66994_CR41","first-page":"613","volume":"55","author":"HD Hutchinson","year":"1977","unstructured":"Hutchinson, H. D., Ziegler, D. W., Wells, D. E. & Nakano, J. H. Differentiation of variola, monkeypox, and vaccinia antisera by radioimmunoassay. Bull. World Health Organ 55, 613\u2013623 (1977).","journal-title":"Bull. World Health Organ"},{"key":"66994_CR42","first-page":"365","volume":"59","author":"SS Marennikova","year":"1981","unstructured":"Marennikova, S. S., Malceva, N. N. & Habahpaseva, N. A. ELISA-a simple test for detecting and differentiating antibodies to closely related orthopoxviruses. Bull. World Health Organ 59, 365\u2013369 (1981).","journal-title":"Bull. World Health Organ"},{"key":"66994_CR43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/vbz.2011.0779","volume":"12","author":"ME Dubois","year":"2012","unstructured":"Dubois, M. E., Hammarlund, E. & Slifka, M. K. Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection. Vector Borne Zoonotic Dis. 400\u2013409 (2012).","journal-title":"Vector Borne Zoonotic Dis."},{"key":"66994_CR44","doi-asserted-by":"publisher","unstructured":"Kinganda-Lusamaki, E. et al. Use of Mpox multiplex serology in the identification of cases and outbreak investigations in the Democratic Republic of the Congo (DRC). Pathogens 12, https:\/\/doi.org\/10.3390\/pathogens12070916 (2023).","DOI":"10.3390\/pathogens12070916"},{"key":"66994_CR45","doi-asserted-by":"publisher","first-page":"e29134","DOI":"10.1002\/jmv.29134","volume":"95","author":"JL Yates","year":"2023","unstructured":"Yates, J. L. et al. Development of a novel serological assay for the detection of mpox infection in vaccinated populations. J. Med Virol. e29134 (2023).","journal-title":"J. Med Virol."},{"key":"66994_CR46","doi-asserted-by":"publisher","unstructured":"Taha, T. Y. et al. Design and optimization of a Monkeypox virus specific serological assay. Pathogens 12, https:\/\/doi.org\/10.3390\/pathogens12030396 (2023).","DOI":"10.3390\/pathogens12030396"},{"key":"66994_CR47","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nm1273","volume":"11","author":"E Hammarlund","year":"2005","unstructured":"Hammarlund, E. et al. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat. Med. 11, 1005\u20131011 (2005).","journal-title":"Nat. Med."},{"key":"66994_CR48","first-page":"100792","volume":"37","author":"MLM Macalinao","year":"2023","unstructured":"Macalinao, M. L. M. et al. Analytical approaches for antimalarial antibody responses to confirm historical and recent malaria transmission: an example from the Philippines. Lancet Reg. Health West Pac. 37, 100792 (2023).","journal-title":"Lancet Reg. Health West Pac."},{"key":"66994_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39670-w","volume":"13","author":"I Byrne","year":"2023","unstructured":"Byrne, I. et al. Serological evaluation of risk factors for exposure to malaria in a pre-elimination setting in Malaysian Borneo. Sci. Rep. 13, 12998 (2023).","journal-title":"Sci. Rep."},{"key":"66994_CR50","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/S2666-5247(20)30197-X","volume":"2","author":"J Rosado","year":"2021","unstructured":"Rosado, J. et al. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. Lancet Microbe 2, e60\u2013e69 (2021).","journal-title":"Lancet Microbe"},{"key":"66994_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97453-7","volume":"11","author":"HH Rashidi","year":"2021","unstructured":"Rashidi, H. H., Dang, L. T., Albahra, S., Ravindran, R. & Khan, I. H. Automated machine learning for endemic active tuberculosis prediction from multiplex serological data. Sci. Rep. 11, 17900 (2021).","journal-title":"Sci. Rep."},{"key":"66994_CR52","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1128\/JVI.02089-12","volume":"87","author":"MB Townsend","year":"2013","unstructured":"Townsend, M. B. et al. Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations. J. Virol. 87, 900\u2013911 (2013).","journal-title":"J. Virol."},{"key":"66994_CR53","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","volume":"211","author":"IJ Amanna","year":"2006","unstructured":"Amanna, I. J., Slifka, M. K. & Crotty, S. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211, 320\u2013337 (2006).","journal-title":"Immunol. Rev."},{"key":"66994_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","volume":"239","author":"B Moss","year":"2011","unstructured":"Moss, B. Smallpox vaccines: targets of protective immunity. Immunol. Rev. 239, 8\u201326 (2011).","journal-title":"Immunol. Rev."},{"key":"66994_CR55","doi-asserted-by":"publisher","first-page":"105957","DOI":"10.1016\/j.isci.2023.105957","volume":"26","author":"R Yefet","year":"2023","unstructured":"Yefet, R. et al. Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens. iScience 26, 105957 (2023).","journal-title":"iScience"},{"key":"66994_CR56","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1128\/JVI.02127-10","volume":"85","author":"J Lantto","year":"2011","unstructured":"Lantto, J. et al. Capturing the natural diversity of the human antibody response against vaccinia virus. J. Virol. 85, 1820\u20131833 (2011).","journal-title":"J. Virol."},{"key":"66994_CR57","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1086\/520936","volume":"196","author":"Y He","year":"2007","unstructured":"He, Y. et al. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine-induced immunity. J. Infect. Dis. 196, 1026\u20131032 (2007).","journal-title":"J. Infect. Dis."},{"key":"66994_CR58","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3390\/pr12071382","volume":"12","author":"L Qu","year":"2024","unstructured":"Qu, L. & Pei, Y. A comprehensive review on discriminant analysis for addressing challenges of class-level limitations, small sample size, and robustness. Processes 12, 1382 (2024).","journal-title":"Processes"},{"key":"66994_CR59","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","volume":"401","author":"O Mitja","year":"2023","unstructured":"Mitja, O. et al. Mpox in people with advanced HIV infection: a global case series. Lancet 401, 939\u2013949 (2023).","journal-title":"Lancet"},{"key":"66994_CR60","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S1473-3099(25)00018-0","volume":"25","author":"D Hillus","year":"2025","unstructured":"Hillus, D. et al. Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study. Lancet Infect. Dis. 25, 775\u2013787 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"66994_CR61","doi-asserted-by":"publisher","first-page":"e0250721","DOI":"10.1128\/spectrum.02507-21","volume":"10","author":"A Cameron","year":"2022","unstructured":"Cameron, A. et al. Simultaneous measurement of IgM and IgG antibodies to SARS-CoV-2 Spike, RBD, and nucleocapsid multiplexed in a single assay on the xMAP INTELLIFLEX DR-SE flow analyzer. Microbiol Spectr. 10, e0250721 (2022).","journal-title":"Microbiol Spectr."},{"key":"66994_CR62","doi-asserted-by":"publisher","first-page":"975398","DOI":"10.3389\/fcimb.2022.975398","volume":"12","author":"KR Chan","year":"2022","unstructured":"Chan, K. R. et al. Serological cross-reactivity among common flaviviruses. Front Cell Infect. Microbiol. 12, 975398 (2022).","journal-title":"Front Cell Infect. Microbiol."},{"key":"66994_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0166-0934(02)00282-3","volume":"108","author":"H Hujakka","year":"2003","unstructured":"Hujakka, H. et al. Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J. Virol. Methods 108, 117\u2013122 (2003).","journal-title":"J. Virol. Methods"},{"key":"66994_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48581-9","volume":"13","author":"D Stern","year":"2023","unstructured":"Stern, D. et al. A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity. Sci. Rep. 13, 21846 (2023).","journal-title":"Sci. Rep."},{"key":"66994_CR65","doi-asserted-by":"publisher","first-page":"e0150110","DOI":"10.1371\/journal.pone.0150110","volume":"11","author":"D Stern","year":"2016","unstructured":"Stern, D. et al. Development of a genus-specific antigen capture ELISA for orthopoxviruses - target selection and optimized screening. PLoS ONE 11, e0150110 (2016).","journal-title":"PLoS ONE"},{"key":"66994_CR66","unstructured":"R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2021)."},{"key":"66994_CR67","doi-asserted-by":"publisher","first-page":"e0187901","DOI":"10.1371\/journal.pone.0187901","volume":"12","author":"H Sanz","year":"2017","unstructured":"Sanz, H. et al. drLumi: An open-source package to manage data, calibrate, and conduct quality control of multiplex bead-based immunoassays data analysis. PLoS One 12, e0187901 (2017).","journal-title":"PLoS One"},{"key":"66994_CR68","first-page":"2825","volume":"12","author":"F Pedrogosa","year":"2011","unstructured":"Pedrogosa, F. et al. Scikit-learn: Machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"66994_CR69","unstructured":"Gallo, G., Ferrari, V., Marcelloni, F. & Ducange, P. in Information Processing and Management of Uncertainty in Knowledge-Based Systems (IPMU 2020) (ed Lesot, M. J.) (Springer, 2020)."},{"key":"66994_CR70","doi-asserted-by":"publisher","first-page":"152","DOI":"10.21037\/atm.2019.03.29","volume":"7","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Predictive analytics with gradient boosting in clinical medicine. Ann. Transl. Med 7, 152 (2019).","journal-title":"Ann. Transl. Med"},{"key":"66994_CR71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/IJNRD.S461028","volume":"17","author":"ED Omar","year":"2024","unstructured":"Omar, E. D. et al. Comparative Analysis of Logistic Regression, Gradient Boosted Trees, SVM, and Random Forest Algorithms for Prediction of Acute Kidney Injury Requiring Dialysis After Cardiac Surgery. Int J. Nephrol. Renovasc Dis. 17, 197\u2013204 (2024).","journal-title":"Int J. Nephrol. Renovasc Dis."},{"key":"66994_CR72","first-page":"507","volume":"35","author":"L Grinsztajn","year":"2022","unstructured":"Grinsztajn, L., Oyallon, E. & Varoquaux, G. Why do tree-based models still outperform deep learning on typical tabular data?. Adv. Neural Inf. Process. Syst. 35, 507\u2013520 (2022).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"66994_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56706-x","volume":"14","author":"O Rainio","year":"2024","unstructured":"Rainio, O., Teuho, J. & Klen, R. Evaluation metrics and statistical tests for machine learning. Sci. Rep. 14, 6086 (2024).","journal-title":"Sci. Rep."},{"key":"66994_CR74","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1006\/viro.1994.1241","volume":"200","author":"H Meyer","year":"1994","unstructured":"Meyer, H., Osterrieder, N. & Czerny, C. P. Identification of binding sites for neutralizing monoclonal antibodies on the 14-kDa fusion protein of orthopox viruses. Virology 200, 778\u2013783 (1994).","journal-title":"Virology"},{"key":"66994_CR75","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1016\/j.vaccine.2010.05.023","volume":"28","author":"R Rudraraju","year":"2010","unstructured":"Rudraraju, R. & Ramsay, A. J. Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection. Vaccine 28, 4997\u20135004 (2010).","journal-title":"Vaccine"},{"key":"66994_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1006\/viro.1995.1378","volume":"211","author":"EJ Wolffe","year":"1995","unstructured":"Wolffe, E. J., Vijaya, S. & Moss, B. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology 211, 53\u201363 (1995).","journal-title":"Virology"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66994-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66994-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66994-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:04:16Z","timestamp":1765584256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66994-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66994"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66994-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4822502\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10943"}}